Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
DISASTERS AVERTED — Near Miss Case Studies
TOP STORIES — Diabetes News and Research
Adherence with Noninsulin Medication for Adolescents with Type 1 Diabetes
The Long Term Effects of Early Glycemic Control in Patients with Diabetes
Reducing New-Onset Type Diabetes with Dalcetrapib
MOST POPULAR ARTICLES OF THE MONTH
#1 A1C levels are Indicators of Coronary Atherosclerotic Plaque Formation
#2 Why CGM?
#3 Did You Know? Metformin, along with dozens of drugs, may have promise against COVID-19
Over the past 5 years all of the SGLT-2 inhibitors have gotten various indications for cardiovascular protection. Now it appears that a drug used for Acute Coronary Syndrome can have very positive benefits in preventing and reversing diabetes. Check out this week’s feature from Chardae Whitner, 2020 PharmD. Candidate, Lake Erie College of Osteopathic Medicine, on the use of dalcetrapib and its effects on diabetes.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
DISASTERS AVERTED — Near Miss Case Studies
We were running a clinical study on erectile dysfunction. An 68-year-old male with obesity came in looking for help for his ED, so he thought he might qualify for the study. He had not had a medical workup for some time and wasn’t aware of any underlying diseases. I recommended he be screened for diabetes….
TOP STORIES — Diabetes News and Research
What factors affect adherence for our young patients?
Minimization of secondary diabetic complications from early glycemic control in type 2 diabetes patients.
Can cholesteryl ester transfer protein inhibitors reduce incident type 2 diabetes?